Answers are grounded in this paper and cite their sources.
Neuroimaging study shows whole-brain volume loss indicates delayed ischaemic injury, suggesting new clinical trial methods.
This study indicates that whole-brain volume loss is a feasible measurement of delayed secondary ischaemic injury. Future neuroprotectant clinical trials could utilise MR-based markers of delayed ischaemic injury.
No takes yet. Share an insight, caveat, or question.
Tadros et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: